Prof. Andreas Beilhack, MD: “Mapping dynamic immune processes within tissues”
Monday, November 14, 2016, 03.00 pm, Vienna Competence Centre, Lazarettgasse 19, 1090 Vienna, seminar room, 1. floor
COLLOQUIUM IN PATHOPHYSIOLOGY, INFECTIOLOGY AND IMMUNOLOGY
Andreas Beilhack heads the Interdisciplinary Center for Clinical Research Laboratory for Experimental Stem Cell Transplantation at the Departments of Medicine II Pediatrics at Würzburg University Medical School since 2012.
He is the coordinator of the Else-Kröner-Research College at Würzburg University, a physician-scientist program for interdisciplinary translational immunology. He studied medicine at the universities of Graz, Vienna, Basel and the City of Hope National Medical Center, USA. He received postdoctoral training at Stanford University, USA. Since then Prof. Beilhack is working on mechanisms responsible for immune regulation in cancer, inflammation and infectious diseases. In 2015 Prof. Beilhack received a second doctoral degree for his work in the field of immunology and graft-versus-host disease from Würzburg University. The scientific contributions of Prof. Beilhack have been recognized by several research awards, including the Best Science Award 2004 of the American Society of Blood and Marrow Transplantation, the First International ADMO Award 2005, the Stowell-Orbison Award 2007, the Pathologist-in-Training-Award 2007, the Chugai Science Award in 2007 as well as the m4-Award of the Bavarian Ministry of Economic Affairs and Media, Energy and Technology in 2015.
Chopra M et al. (2016) Exogenous TNFR2 activation protects from acute GvHD by induction of host Treg expansion. J Exp Med 213: 1881–1900.
Chopra M et al. (2015) Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GvHD. Blood 126: 437–44.
Rieber N et al. (2015) Pathogenic fungi regulate T-cell immunity by inducing neutrophilic myeloidderived suppressor cells through a Dectin-1/CARD9 and ROS-mediated mechanism. Cell Host Microbe 17: 507–14.
Ulges A et al. (2015) Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo. Nat Immunol 16: 267–75.
Vaeth M et al., (2015) Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity. Proc Natl Acad Sci USA 112: 1125–30.
Brede C et al. (2012) Mapping immune processes in intact tissues at cellular resolution. J Clin Invest 122: 4439–46.
Host: Hannes Stockinger
back to: CePII